This Med-tech company’s turnaround is driven by operational restructuring, a focus on higher-margin U.S. markets, and a patient-first approach under its new CEO; The company has reported two consecutive quarters of profitability, with strong revenue growth and flat operating expenses; We expect a near-term upside of at least 100%; Key catalysts include continued sales and EPS growth, as well as the divestiture of part of the business.
Today, I want to address a comment made by a personality on X with a large following and a subscription service of his own, albeit not in investing. I like to give credence to the fact that investing in high-quality microcaps can produce outsized returns, and in doing so, I often cite some statistics that support my suppositions, especially when it comes to setting the record straight on negative stereotypes surrounding microcaps.
Our October 9, 2024, conversation with Dan Schum, founder of NoNameStocks.com, provided a deep dive into the world of microcap and OTC stock investing. This is the second time Dan has been a guest on our Podcast, his first appearance being in 2020. Dan used to have a presence on X under the @nonamestocks handle, but left the platform in 2023. So, we wanted to see what Dan has been up to in the world of the OTC and dark stocks. This was a great conversation, where we covered about 10 stocks, many of which are in our own coverage universe. If you used to follow Dan and are wondering how he feels about some of the stocks he used to talk about on X, this is a must-listen Investor Insights Skull Session.
This week, we’d like to rewind the month of September and quickly spotlight a few of clips from Skull Sessions that we held – clips that we promised we’d extract with hopes that they’d inspire you to watch the rest of the events in case you missed them. They included 4 microcap management executive Skull Sessions and 2 talks with investing peers, both of which spoke with us about some bullish stock pitches.
In This Month’s GeoWire September was a busy month of events, filling in the gap for slow microcap earnings flow. 5 microcap management Skull sessions (TGEN, CVALF (COV.V), TSSI) and 2 peer discussions (Dakota Quint and Deep Sail Capital) Another […]